Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Kharfan-Dabaja, M.A.; Labopin, M.; Bazarbachi, A.; Socie, G.; Kroeger, N.; Blaise, D.; ... ; Mohty, M. (2015)

Article / Letter to editor

• Acute myeloid leukemia
• Second complete remission
• Leukemia-free survival
• Overall survival
• Allogeneic hematopoietic cell transplantation

• All authors: Kharfan-Dabaja, M.A.; Labopin, M.; Bazarbachi, A.; Socie, G.; Kroeger, N.; Blaise, D.; Veelken, H.; Bermudez, A.; Or, R.; Lioure, B.; Beelen, D.; Fegueux, N.; Hamladji, R.M.; Nagler, A.; Mohty, M.
• Date: 2015-09-30
• Journal: Leukemia Research
• Volume: 39
• Issue: 9
• Pages: 933 - 937
• DOI: doi:10.1016/j.leukres.2015.04.009